ArticleAlimentary pharmacology & therapeutics2020

Vedolizumab use is not associated with increased malignancy incidence: GEMINI LTS study results and post-marketing data.

Timothy Card et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.